Sam is a professional trader and the lead stock market news writer at AskTraders. After starting his career in the forex market, Sam now focuses on gold and stocks with a preference for fundamental and macroeconomic analysis.
Shares of Oxford Nanopore Technologies have gained Tuesday after the company updated its revenue guidance.
The update is a result of the company's significant expansion in a large customer project in the UAE.
On November 9, 2021, Oxford Nanopore was awarded a 36-month contract to provide devices, consumables, including flow cells and kits, and other support services worth approximately $68 million.
The new contract with G42 Laboratory, which provides sequencing operations in the project, is expected to generate revenues primarily after 2021.
Therefore, the company previously said it is maintaining its guidance of core Life Science Research Tools (LSRT) revenue of £105 million to £111 million in FY21, resulting from 60-70% growth.
However, they added that given the scale of the new contract, it is now introducing guidance for LSRT revenue of £135 million to £145 million for FY22.
Oxford Nanopore is also upgrading its LSRT revenue guidance for FY23 to between £170 million and £190 million, compared to its previous expectation of between £165 million and £175 million.
As investors would have expected, the company's share price has rallied on the news, trading over 6.7% above Monday's close at 582.5p.
One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It's a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .